found that the use of Lactobacillus rhamnosus GG, Lactobacillus acidophilus, or combination with celecoxib in a colorectal cancer animal model reduced NF-κB, COX-2, β-catenin, and K-ras carcinogenic biomarkers (43). This evidence concerns the gene NFKB1 and colorectal cancer.